Mynaric AG (MYNA) Company Overview

MUNICH, DE / ACCESS Newswire / January 31, 2025 / Mynaric AG (NASDAQ:MYNA)(ISIN: US62857X1019)(FRA:M0YN)(ISIN: DE000A31C305) (the "Company") announces the extension of the maturity of its three bridge loans and the expectation to agree on a fourth bridge loan, a separate restructuring loan and an application for the initiation of a financial reorganization under the German Corporate Stabilization and Restructuring Act (Gesetz über den Stabilisierungs- und Restrukturierungsrahmen für Unternehmen ("StaRUG"). New maturity date of bridge loans The Company today entered into an amendment to its existing loan agreement with its U.S.-based lenders, which are funds affiliated with a U.S.-based global investment management firm (the "Lenders"), pursuant to which the Lenders have agreed to extend the maturity date of the three existing bridge loans in the aggregate amount of USD 21.5 million from January 31, 2025 to February 7, 2025.

MUNICH, DE / ACCESS Newswire / January 29, 2025 / Mynaric (NASDAQ:MYNA)(FRA:M0YN), a leading provider of industrialized, cost-effective and scalable laser communications products, announces that it received a notification letter dated January 23, 2025 (the "Deficiency Letter") from the Listing Qualifications Department of The Nasdaq Stock Market Inc. (the "Nasdaq") notifying that Mynaric is no longer in compliance with the Nasdaq continued listing criteria, including the Nasdaq Listing Rule 5450(a)(1) due to its failure to meet the minimum closing bid price per share of Mynaric's American Depositary Shares representing its ordinary shares (the "ADS") of $1.00 for a period of 30 consecutive business days (the "Minimum Bid Price Requirement"). The Deficiency Letter has no immediate effect on the listing of Mynaric's ADS, which continue to trade under the symbol "MYNA.

MUNICH, DE / ACCESSWIRE / January 15, 2025 / Mynaric (NASDAQ:MYNA)(FRA:M0YN), a leading provider of industrialized, cost-effective and scalable laser communications products, today announced that it received a notification letter dated January 9, 2025 (the "Deficiency Letter I") from the Listing Qualifications Department of The Nasdaq Stock Market Inc. (the "Nasdaq") notifying that Mynaric is no longer in compliance with the Nasdaq continued listing criteria, including the Nasdaq Listing Rule 5250(c)(2) due to its failure to file an interim balance sheet and income statement as of the end of its second quarter on Form 6-K no later than six months following the end of the Mynaric's second quarter (the "Interim Reporting Requirement"). Furthermore, Mynaric today announced that it received a notification letter dated January 13, 2025 (the "Deficiency Letter II") from Nasdaq notifying that Mynaric is no longer in compliance with Listing Rule 5620(a) due to its failure to hold an annual meeting of shareholders within twelve months of the end of the Mynaric's fiscal year (the "Annual Meeting Requirement").

MUNICH, DE / ACCESSWIRE / January 3, 2025 / Mynaric AG (NASDAQ:MYNA; ISIN: US62857X1019)(FRA:M0YN; ISIN: DE000A31C305) (the "Company") updates its full-year 2024 guidance published on August 20, 2024, for two of its key financial performance metrics. IFRS-15 revenue: the Company now anticipates full-year 2024 IFRS-15 revenue of EUR 14.1 million compared to previous guidance of a range estimating between EUR 16.0 million to EUR 24.0 million.

NEW YORK , Dec. 30, 2024 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of Mynaric AG (NASDAQ: MYNA) securities between June 20, 2024 and October 7, 2024, both dates inclusive (the "Class Period"), of the important December 30, 2024 lead plaintiff deadline. So what: If you purchased Mynaric securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

NEW YORK, Dec. 30, 2024 (GLOBE NEWSWIRE) -- Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Mynaric AG (“Mynaric” or “the Company”) (NASDAQ: MYNA) and certain of its officers.

LOS ANGELES--(BUSINESS WIRE)--MYNA Investors Have Opportunity to Lead Mynaric AG Securities Fraud Lawsuit with the Schall Law Firm.

NEW YORK, NY / ACCESSWIRE / December 30, 2024 / Pomerantz LLP announces that a class action lawsuit has been filed against Mynaric AG ("Mynaric" or the "Company") (NASDAQ:MYNA) and certain officers. The class action, filed in the United States District Court for the Eastern District Of New York, and docketed under 24-cv-07602 is on behalf of a class consisting of all persons and entities other than Defendants that purchased or otherwise acquired Mynaric securities between June 20, 2024 and October 7, 2024, both dates inclusive (the "Class Period"), seeking to recover damages caused by Defendants' violations of the federal securities laws and to pursue remedies under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 (the "Exchange Act") and Rule 10b-5 promulgated thereunder, against the Company and certain of its top officials.

LOS ANGELES , Dec. 30, 2024 /PRNewswire/ --  The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Mynaric AG ("Mynaric" or "the Company") (NASDAQ: MYNA) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between June 20, 2024 and October 7, 2024, inclusive (the "Class Period"), are encouraged to contact the firm before December 30, 2024.